Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

By  

Current Alzheimer Research, Vol. 5, Iss. 1, 2008-02 ,pp. : 83-89

Bentham Science Publishers

Access to resources Recommend Favorite

Declarative and Procedural Learning, Quantitative Measures of the Hippocampus, and Subcortical White Alterations in Alzheimer's Disease and Ischaemic Vascular Dementia

By Libon David J   Bogdanoff Bruce   Cloud Blaine S   Skalina Stefan   Giovannetti Tania   Gitlin Heather L   Bonavita John  

Journal of Clinical and Experimental Neuropsychology (Neuropsychology, Developm, Vol. 20, Iss. 1, 1998-02 ,pp. : 30-41

Routledge Ltd

Access to resources Recommend Favorite

Declarative and Nondeclarative Sequence Learning Tasks: Closed-Head Injured Patients Versus Control Participants

By Vakil Eli   Gordon Yael   Birnstok Shira   Aberbuch Sara   Groswasser Zeev  

Journal of Clinical and Experimental Neuropsychology (Neuropsychology, Developm, Vol. 23, Iss. 2, 2001-04 ,pp. : 207-214

Routledge Ltd

Access to resources Recommend Favorite

Cholinesterase inhibitors in Alzheimer’’s disease: sooner or later or both?

By Kerwin Robert  

Future Neurology, Vol. 1, Iss. 6, 2006-11 ,pp. : 737-740

Future Medicine

Access to resources Recommend Favorite

Temporal and Cerebellar Brain Regions that Support both Declarative Memory Formation and Retrieval

By Weis Susanne   Klaver Peter   Reul Jürgen   Elger Christian E.   Fernández Guillén  

Cerebral Cortex, Vol. 14, Iss. 3, 2004-03 ,pp. : 256-267

Oxford University Press

Access to resources Recommend Favorite